Pharmaceutical Composition or Health Functional Food for Prevention and Treatment of Obesity Containing Powder of Novel Hybrid Mushroom as Active Ingredient
AssigneesNovacell Technology Inc., Gyongsangbuk-do
InventorsTae Hoon LEE, Jae Wang GHIM
Life of this patent
Estimating the term…
Abstract
The present invention provides a pharmaceutical composition for the treatment of obesity and fatty liver disease caused due to a high-fat diet, containing, as an active ingredient, the powder of a fruiting body or a mycelium of hybrid mushroom strain GBN2WP0970 having no side effects and an excellent triglyceride absorption inhibitory effect.
Claims6
A method for treating fatty liver disease due to a high-fat diet in a subject, comprising administering a therapeutically effective amount of powder of a fruiting body or a mycelium of hybrid mushroom Pleurotus sp. GBN2WP0970 to the subject.
A method for treating obesity due to a high-fat diet in a subject, comprising administering a therapeutically effective amount of powder of a fruiting body or a mycelium of hybrid mushroom Pleurotus sp. GBN2WP0970 to the subject.
Dependencies are inferred from the claim text.